What is the maximum recommended daily dose of gabapentin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Daily Dose of Gabapentin

The maximum recommended daily dose of gabapentin is 3600 mg per day, divided into three doses (1200 mg three times daily). 1

FDA-Approved Dosing

The FDA drug label clearly establishes that:

  • Doses up to 3600 mg/day have been administered to patients and have been well tolerated 1
  • The standard maximum is 3600 mg/day divided into three doses (1200 mg TID)
  • Doses of 2400 mg/day have been well tolerated in long-term clinical studies 1
  • The maximum time between doses should not exceed 12 hours 1

Clinical Guideline Recommendations

The Mayo Clinic neuropathic pain guidelines align with FDA labeling, recommending titration until pain relief, dose-limiting adverse effects, or 3600 mg/day in 3 divided doses is reached 2. An adequate trial at maximum dose requires 3-8 weeks for titration plus 2 weeks at the maximum dose 2.

Evidence for Efficacy at Maximum Dose

High-quality Cochrane systematic review data demonstrates that gabapentin at 1200 mg daily or greater provides:

  • Substantial benefit (≥50% pain relief) in 32% of postherpetic neuralgia patients vs 17% with placebo (NNT 6.7) 3
  • Substantial benefit in 38% of diabetic neuropathy patients vs 21% with placebo (NNT 5.9) 3

Research indicates that doses of 1800-3600 mg/day are most effective, with comparable effects across this dose range, though additional benefit above 1800 mg/day was not consistently demonstrated 2.

Critical Dosing Considerations

Renal Impairment

Dose reduction is mandatory in renal insufficiency 2, 1:

  • CrCl ≥60 mL/min: 900-3600 mg/day (no adjustment needed)
  • CrCl 30-59 mL/min: Maximum 1400 mg/day
  • CrCl 15-29 mL/min: Maximum 700 mg/day
  • CrCl <15 mL/min: Maximum 300 mg/day
  • Hemodialysis patients require supplemental post-dialysis dosing 1

Pharmacokinetic Limitations

Gabapentin has nonlinear, saturable absorption 1, 4. Plasma concentrations are proportional to dose only up to 1800 mg/day due to saturable intestinal transport mechanisms 4. This means higher doses don't necessarily produce proportionally higher blood levels, which partly explains why doses above 1800 mg/day may not provide substantially greater benefit 2.

Geriatric Patients

Lower starting doses and slower titration are recommended in elderly patients 2, 1, though the same maximum of 3600 mg/day applies if tolerated.

Safety at Maximum Dose

At 3600 mg/day, gabapentin remains generally well-tolerated:

  • Adverse event withdrawals: 11% vs 8.2% placebo (NNH 30) 3
  • Common side effects: dizziness (19%), somnolence (14%), peripheral edema (7%), gait disturbance (14%) 3
  • Serious adverse events are not significantly increased compared to placebo 3

Practical Titration to Maximum Dose

Start at 300 mg at bedtime or 300 mg three times daily, then increase by 100-300 mg every 1-7 days as tolerated 2, 1. The typical titration schedule:

  • Day 1: 300 mg once daily
  • Day 2: 300 mg twice daily (600 mg/day)
  • Day 3: 300 mg three times daily (900 mg/day)
  • Continue increasing by 300 mg every few days until reaching 3600 mg/day or dose-limiting side effects occur 1

Bottom line: 3600 mg/day in three divided doses is the established maximum, supported by both FDA labeling and clinical guidelines, with mandatory dose reduction for renal impairment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.